{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:14:01Z","timestamp":1771031641072,"version":"3.50.1"},"reference-count":52,"publisher":"Impact Journals, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,3,31]]},"DOI":"10.18632\/aging.204579","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T21:19:21Z","timestamp":1679347161000},"page":"1964-1976","source":"Crossref","is-referenced-by-count":7,"title":["Clinical significance and integrative analysis of the cuproptosis-associated genes in head and neck squamous cell carcinoma"],"prefix":"10.18632","volume":"15","author":[{"given":"Qiu","family":"Peng","sequence":"first","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjie","family":"Jiang","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiming","family":"Tan","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longzheng","family":"Xia","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayiyuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinguan","family":"Lin","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Oyang","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Tang","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjing","family":"Peng","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Su","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Luo","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqian","family":"Han","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianjin","family":"Liao","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"},{"name":"Public Service Platform of Tumor Organoids Technology, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"},{"name":"Public Service Platform of Tumor Organoids Technology, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"7","author":"Bray","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.","volume":"5","author":"Abu-Raddad","year":"2019","journal-title":"JAMA Oncol"},{"key":"3","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/annonc\/mdz084","article-title":"Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden.","volume":"3","author":"Boffetta","year":"2019","journal-title":"Ann Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.21053\/ceo.2020.01732","article-title":"Survival Benefits From Surgery for Stage IVa Head and Neck Squamous Cell Carcinoma: A Multi-institutional Analysis of 1,033 Cases.","volume":"1","author":"Ahn","year":"2021","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"5","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1517\/14656566.2015.1085507","article-title":"Pharmacotherapy of head and neck cancer.","volume":"1","author":"Adelstein","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.trecan.2018.03.006","article-title":"New Therapies in Head and Neck Cancer.","volume":"4","author":"Grandis","year":"2018","journal-title":"Trends Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death.","volume":"2","author":"Kroemer","year":"2019","journal-title":"Cell Res"},{"key":"8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trecan.2021.09.003","article-title":"Necroptosis and tumor progression.","volume":"8","author":"Liu","year":"2022","journal-title":"Trends Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease.","volume":"1","author":"Green","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death.","volume":"14","author":"Stockwell","year":"2012","journal-title":"Cell"},{"key":"11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy.","volume":"1","author":"El-Deiry","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation.","volume":"7","author":"Cookson","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"13","doi-asserted-by":"publisher","first-page":"938259","DOI":"10.3389\/fgene.2022.938259","article-title":"Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.","volume":"1","author":"Zhang","year":"2022","journal-title":"Front Genet"},{"key":"14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease.","volume":"2","author":"Conrad","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins.","volume":"37","author":"Kocak","year":"2022","journal-title":"Science"},{"key":"16","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.molmed.2021.06.014","article-title":"Ferroptosis in the tumor microenvironment: perspectives for immunotherapy.","volume":"2","author":"Bi","year":"2021","journal-title":"Trends Mol Med"},{"key":"17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/s0369-8114(02)00290-0","article-title":"[Role of intracellular zinc in programmed cell death].","volume":"5","author":"Favier","year":"2002","journal-title":"Pathol Biol (Paris)"},{"key":"18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fcell.2020.00629","article-title":"A Novel Ten-Gene Signature Predicting Prognosis in Hepatocellular Carcinoma.","volume":"8","author":"Tang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.","volume":"6","author":"Schultz","year":"2013","journal-title":"Sci Signal"},{"key":"20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.","volume":"2","author":"Goldberg","year":"2012","journal-title":"Cancer Discov"},{"key":"21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12935-020-1113-6","article-title":"Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.","volume":"2","author":"Yu","year":"2020","journal-title":"Cancer Cell Int"},{"key":"22","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.omtn.2021.04.003","article-title":"mA-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD.","volume":"2","author":"Lin","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"23","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3389\/fonc.2020.00796","article-title":"Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups.","volume":"1","author":"Qiu","year":"2020","journal-title":"Front Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"8395","DOI":"10.2147\/OTT.S257200","article-title":"Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma.","volume":"1","author":"Xue","year":"2020","journal-title":"Onco Targets Ther"},{"key":"25","doi-asserted-by":"publisher","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology.","volume":"3","author":"Aneichyk","year":"2019","journal-title":"Bioinformatics"},{"key":"26","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells.","volume":"4","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.18632\/aging.103787","article-title":"Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database.","volume":"1","author":"Wei","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"28","doi-asserted-by":"publisher","first-page":"djw144","DOI":"10.1093\/jnci\/djw144","article-title":"Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types.","volume":"10","author":"Vincent","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"29","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049","article-title":"Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.","volume":"15","author":"Akbani","year":"2014","journal-title":"Cell"},{"key":"30","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.18632\/aging.102814","article-title":"Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.","volume":"1","author":"Chen","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"31","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.","volume":"2","author":"Brown","year":"2018","journal-title":"Nat Med"},{"key":"32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.neo.2019.04.003","article-title":"Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome.","volume":"2","author":"Yan","year":"2019","journal-title":"Neoplasia"},{"key":"33","doi-asserted-by":"publisher","first-page":"650673","DOI":"10.3389\/fonc.2021.650673","article-title":"Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients.","volume":"1","author":"Sun","year":"2021","journal-title":"Front Oncol"},{"key":"34","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","article-title":"Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines.","volume":"1","author":"Huang","year":"2014","journal-title":"Genome Biol"},{"key":"35","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/pmic.201500409","article-title":"Manual evaluation of tissue microarrays in a high-throughput research project: The contribution of Indian surgical pathology to the Human Protein Atlas (HPA) project.","volume":"1","author":"Navani","year":"2016","journal-title":"Proteomics"},{"key":"36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41591-019-0374-x","article-title":"Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy.","volume":"2","author":"O'Neill","year":"2019","journal-title":"Nat Med"},{"key":"37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.21101\/cejph.a5565","article-title":"Environmental and behavioural head and neck cancer risk factors.","volume":"2","author":"Bruzzone","year":"2019","journal-title":"Cent Eur J Public Health"},{"key":"38","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4103\/0973-1482.180687","article-title":"Epidemiological profile of head and neck cancer patients in Western Uttar Pradesh and analysis of distributions of risk factors in relation to site of tumor.","volume":"1","author":"Perween","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer.","volume":"1","author":"Brakenhoff","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"40","doi-asserted-by":"publisher","first-page":"959456","DOI":"10.3389\/fgene.2022.959456","article-title":"A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma.","volume":"1","author":"Xie","year":"2022","journal-title":"Front Genet"},{"key":"41","doi-asserted-by":"publisher","first-page":"11325","DOI":"10.1038\/s41598-022-15251-1","article-title":"A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma.","volume":"1","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"42","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2147\/PGPM.S372824","article-title":"Cuproptosis-Related Gene -and- Polymorphisms are Associated with Risk of Lung Cancer.","volume":"1","author":"Jing","year":"2022","journal-title":"Pharmgenomics Pers Med"},{"key":"43","doi-asserted-by":"publisher","first-page":"961213","DOI":"10.3389\/fonc.2022.961213","article-title":"Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.","volume":"1","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"44","doi-asserted-by":"publisher","first-page":"927706","DOI":"10.3389\/fonc.2022.927706","article-title":"A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG\/miR-193a-3p\/TNFRSF21 regulatory axis in lung adenocarcinoma.","volume":"1","author":"Xu","year":"2022","journal-title":"Front Oncol"},{"key":"45","doi-asserted-by":"publisher","first-page":"930041","DOI":"10.3389\/fphar.2022.930041","article-title":"Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma.","volume":"1","author":"Xu","year":"2022","journal-title":"Front Pharmacol"},{"key":"46","doi-asserted-by":"publisher","first-page":"8489387","DOI":"10.1155\/2022\/8489387","article-title":"A Newly Established Cuproptosis-Associated Long Non-Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft Tissue Sarcoma.","volume":"202","author":"Wang","year":"2022","journal-title":"J Oncol"},{"key":"47","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.compbiomed.2022.105924","article-title":"A Cuproptosis Activation Scoring model predicts neoplasm-immunity interactions and personalized treatments in glioma.","volume":"14","author":"Li","year":"2022","journal-title":"Comput Biol Med"},{"key":"48","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/genes13050851","article-title":"A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.","volume":"1","author":"Xie","year":"2022","journal-title":"Genes (Basel)"},{"key":"49","doi-asserted-by":"publisher","first-page":"947551","DOI":"10.3389\/fgene.2022.947551","article-title":"Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.","volume":"1","author":"Liu","year":"2022","journal-title":"Front Genet"},{"key":"50","doi-asserted-by":"publisher","first-page":"942785","DOI":"10.3389\/fgene.2022.942785","article-title":"The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma.","volume":"1","author":"Wei","year":"2022","journal-title":"Front Genet"},{"key":"51","doi-asserted-by":"publisher","first-page":"e004512","DOI":"10.1136\/jitc-2022-004512","article-title":"T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma.","volume":"1","author":"Rocco","year":"2022","journal-title":"J Immunother Cancer"},{"key":"52","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/annonc\/mdx029","article-title":"Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal.","volume":"2","author":"Saraf","year":"2017","journal-title":"Ann Oncol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T17:23:06Z","timestamp":1680801786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,3,31]]}},"alternative-id":["204579","36947706"],"URL":"https:\/\/doi.org\/10.18632\/aging.204579","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]}}}